Elevated IL-6 has also been linked to aggressive tumor features such as larger tumor size, high grade, and hormone-receptor negativity in some studies, which was consistent with an inflammatory phenotype often seen in triple-negative and HER2+ tumors. This evidence concerns the gene ERBB2 and neoplasm.